Yarrow Bioscience Inc
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-29.1M | $-14.1M | $-4.6M |
| Depreciation & Amortization | — | — | — |
| Depreciation | — | — | — |
| Amortization | — | — | — |
| Stock-Based Compensation | $5.3M | $573.0K | $65.0K |
| Net Cash from Operating Activities | $-28.2M | $-2.3M | $-4.2M |
| Investing Activities | |||
| Capital Expenditures | $27.0K | $31.0K | $0 |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-15.1M | $-37.5M | $0 |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $49.5M | $0 | $47.7M |
| Net Change in Cash | $6.2M | $-39.8M | $43.5M |
| Free Cash Flow | $-28.2M | $-2.3M | $-4.2M |